US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
PT1104760E
(pt)
*
|
1999-12-03 |
2003-06-30 |
Pfizer Prod Inc |
Compostos de sulfamoil-heteroarilpirazole como agentes analgesicos e anti-inflamatorios
|
US6555581B1
(en)
|
2001-02-15 |
2003-04-29 |
Jones Pharma, Inc. |
Levothyroxine compositions and methods
|
ATE297913T1
(de)
|
2001-07-05 |
2005-07-15 |
Pfizer Prod Inc |
Sulfonyl-heteroaryl-triazole als entzündungshemmende und analgetische mittel
|
DE10135027A1
(de)
*
|
2001-07-18 |
2003-02-06 |
Solvay Pharm Gmbh |
Verwendung Trifluoracetylalkyl-substituierter Phenyl-, Phenol- und Benzoylderivate in der Behandlung und/oder Prophylaxe von Obestias und deren Begleit- und/oder Folgeerkrankungen
|
WO2003037874A1
(en)
|
2001-11-02 |
2003-05-08 |
Pfizer Products Inc. |
An efficient synthesis of 5-heteroatom-containing-pyrazoles
|
WO2003037330A1
(en)
|
2001-11-02 |
2003-05-08 |
Pfizer Products Inc. |
Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
|
WO2003037352A1
(en)
*
|
2001-11-02 |
2003-05-08 |
Pfizer Products Inc. |
1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
|
WO2003037351A1
(en)
|
2001-11-02 |
2003-05-08 |
Pfizer Products Inc. |
Heterocyclo-alkylsulfonyl pyrazoles and their use as cox-2 inhibitors
|
WO2003037335A1
(en)
|
2001-11-02 |
2003-05-08 |
Pfizer Products Inc. |
5-heteroatom-substituted pyrazoles
|
DE10162121A1
(de)
*
|
2001-12-12 |
2003-06-18 |
Berolina Drug Dev Ab Svedala |
Deuterierte substituierte Pyrazolyl-Benzolsulfonamide sowie diese Verbindungen enthaltende Arzneimittel
|
SG128438A1
(en)
|
2002-03-15 |
2007-01-30 |
Sumitomo Chemical Co |
Polymer compound and polymer light emitting deviceusing the same
|
US7235560B2
(en)
*
|
2002-08-19 |
2007-06-26 |
Glaxo Group Limited |
Pyrimidine derivative as selective COX-2 inhibitors
|
DE10261807A1
(de)
*
|
2002-12-19 |
2004-07-01 |
Turicum Drug Development Ag |
Deuterierte Catecholaminderivate sowie diese Verbindungen enthaltende Arzneimittel
|
JP2004326857A
(ja)
|
2003-04-22 |
2004-11-18 |
Sony Corp |
光磁気ディスクおよびその記録再生方法
|
WO2005041885A2
(en)
*
|
2003-10-31 |
2005-05-12 |
Metaphore Pharmaceuticals, Inc. |
Compositions and methods for treating, preventing, reversing and inhibiting pain
|
US7863274B2
(en)
*
|
2005-07-29 |
2011-01-04 |
Concert Pharmaceuticals Inc. |
Deuterium enriched analogues of tadalafil as PDE5 inhibitors
|
KR101380190B1
(ko)
*
|
2005-07-29 |
2014-04-11 |
콘서트 파마슈티컬즈, 인크. |
벤조 〔d〕〔1,3〕―디옥솔 유도체
|
CA2624179A1
(en)
*
|
2005-10-06 |
2007-04-12 |
Auspex Pharmaceuticals, Inc. |
Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
|
DK1954669T3
(da)
|
2005-12-01 |
2015-10-12 |
Auspex Pharmaceuticals Inc |
Substituerede phenethylaminer med serotonerg og/eller norepinephrinerg aktivitet
|
UA97795C2
(uk)
*
|
2006-02-17 |
2012-03-26 |
Бьордз Фарма Гмбх Бероліна Інновейтів Ресерч Унд Девелопмент Сервісіз |
Дейтеровані похідні катехоламіну і медикаменти, що містять згадані сполуки
|
EP1993994A2
(en)
*
|
2006-03-16 |
2008-11-26 |
Vertex Pharmceuticals Incorporated |
Deuterated hepatitis c protease inhibitors
|
WO2007140189A2
(en)
*
|
2006-05-26 |
2007-12-06 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted carboxylic acid compounds
|
AU2007256893A1
(en)
*
|
2006-06-05 |
2007-12-13 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
|
US20080039473A1
(en)
*
|
2006-08-08 |
2008-02-14 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects
|
US20110053964A1
(en)
*
|
2006-08-22 |
2011-03-03 |
Roger Tung |
4-aminoquinazoline derivatives and methods of use thereof
|
JP2010501572A
(ja)
*
|
2006-08-22 |
2010-01-21 |
コンサート ファーマシューティカルズ インコーポレイテッド |
4−アミノキナゾリン誘導体およびその使用方法
|
US20080103154A1
(en)
*
|
2006-08-24 |
2008-05-01 |
Concert Pharmaceuticals Inc. |
3, 4-dihydro-2(IH)-quinolinone and 2(1H)-quinolinone derivatives
|
JP2010507585A
(ja)
*
|
2006-10-19 |
2010-03-11 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
置換インドール
|
WO2008066620A2
(en)
*
|
2006-10-20 |
2008-06-05 |
Concert Pharmaceuticals Inc. |
Dibenzothiazepine derivatives
|
US20080280927A1
(en)
*
|
2006-10-20 |
2008-11-13 |
Concert Pharmaceuticals Inc. |
3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
|
US20090270425A1
(en)
*
|
2006-10-20 |
2009-10-29 |
Concert Pharmaceuticals Inc. |
3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
|
AU2007329728A1
(en)
*
|
2006-10-20 |
2008-06-12 |
Concert Pharmaceuticals Inc. |
3-(dihydro-1H-pyrazolo (4,3-d) pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
|
US20090197899A1
(en)
*
|
2006-10-20 |
2009-08-06 |
Concert Pharmaceuticals Inc. |
3-(Dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide Derivatives and Methods of Use
|
US8796267B2
(en)
*
|
2006-10-23 |
2014-08-05 |
Concert Pharmaceuticals, Inc. |
Oxazolidinone derivatives and methods of use
|
CA2703011A1
(en)
*
|
2006-10-23 |
2008-10-23 |
Concert Pharmaceuticals Inc. |
Oxazolidinone derivatives and methods of use
|
US7932235B2
(en)
*
|
2006-11-17 |
2011-04-26 |
Concert Pharmaceuticals, Inc. |
Triazolyl tropane derivatives
|
US20080146573A1
(en)
*
|
2006-12-04 |
2008-06-19 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted oxzolidinones
|
EP2121572A2
(en)
*
|
2006-12-08 |
2009-11-25 |
Auspex Pharmaceuticals Inc. |
Preparation and utility of substituted allylamines
|
US20100260674A1
(en)
*
|
2006-12-15 |
2010-10-14 |
Concert Pharmaceuticals, Inc. |
Quinazoline derivatives and methods of treatment
|
US8343950B2
(en)
*
|
2006-12-15 |
2013-01-01 |
Concert Pharmaceuticals, Inc. |
Quinazoline derivatives and methods of treatment
|
US20090325976A1
(en)
*
|
2006-12-21 |
2009-12-31 |
Concert Pharmaceuticals Inc. |
Prostacyclin derivatives
|
US8080549B2
(en)
*
|
2007-01-12 |
2011-12-20 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
WO2008088727A2
(en)
*
|
2007-01-12 |
2008-07-24 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
US20080262006A1
(en)
*
|
2007-02-02 |
2008-10-23 |
Harbeson Scott L |
Selective endothelin type-a antagonists
|
US20100076010A1
(en)
*
|
2007-02-26 |
2010-03-25 |
Concert Pharmaceuticals, Inc. |
Alpha 1a-adrenoceptor antagonists
|
WO2008106125A2
(en)
*
|
2007-02-26 |
2008-09-04 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of silodosin as alpha la-adrenoceptor antagonists
|
ES2395241T3
(es)
*
|
2007-03-07 |
2013-02-11 |
Concert Pharmaceuticals Inc. |
Derivados deuterados de piperazina como compuestos antianginosos
|
EP3103790B1
(en)
|
2007-03-15 |
2018-05-09 |
Auspex Pharmaceuticals, Inc. |
Substituted phenethylamine with serotoninergic and/or norepinephrinergic activity
|
ES2559838T3
(es)
|
2007-03-16 |
2016-02-16 |
Concert Pharmaceuticals, Inc. |
Inhibidores de proteína de transferencia de ésteres de colesterol
|
WO2008122010A1
(en)
*
|
2007-04-02 |
2008-10-09 |
Concert Pharmaceuticals, Inc. |
Pharmaceutical calcimimetics
|
KR101502959B1
(ko)
*
|
2007-04-11 |
2015-03-16 |
깃세이 야쿠힌 고교 가부시키가이샤 |
5원환 헤테로환 유도체 및 그 의약 용도
|
US8198305B2
(en)
*
|
2007-04-13 |
2012-06-12 |
Concert Pharmaceuticals Inc. |
1,2-benzisoxazol-3-yl compounds
|
US8349817B2
(en)
*
|
2007-04-25 |
2013-01-08 |
Concert Pharmaceuticals, Inc. |
Analogues of cilostazol
|
EP2527336A1
(en)
*
|
2007-04-25 |
2012-11-28 |
Concert Pharmaceuticals Inc. |
Deuterated analogues of cilostazol
|
CN101687868B
(zh)
*
|
2007-05-01 |
2012-12-12 |
康塞特医药品公司 |
吗啡烷化合物
|
EP2150525A1
(en)
*
|
2007-05-01 |
2010-02-10 |
Concert Pharmaceuticals Inc. |
Naphthyl(ethyl) acetamides
|
FI3825306T3
(fi)
|
2007-05-01 |
2023-08-23 |
Concert Pharmaceuticals Inc |
Morfinaaniyhdisteitä
|
US20080280991A1
(en)
*
|
2007-05-08 |
2008-11-13 |
Auspex Pharmaceuticals, Inc. |
Substituted naphthalenes
|
WO2008141021A1
(en)
*
|
2007-05-08 |
2008-11-20 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of tetrahydrotriazolopyrazine compounds and their use as dpp-iv inhibitors
|
US20080306151A1
(en)
*
|
2007-06-11 |
2008-12-11 |
Protia, Llc |
Deuterium-enriched fenofibrate
|
DE602008000255D1
(de)
|
2007-06-12 |
2009-12-17 |
Concert Pharmaceuticals Inc |
Azapeptid-Derivate als HIV-Protease-Inhibitoren
|
JP2010529994A
(ja)
*
|
2007-06-13 |
2010-09-02 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
置換ピペラジン
|
US20090005366A1
(en)
*
|
2007-06-19 |
2009-01-01 |
Protia, Llc |
Deuterium-enriched olanzapine
|
US20080318920A1
(en)
*
|
2007-06-19 |
2008-12-25 |
Protia, Llc |
Deuterium-enriched ezetimibe
|
US20080319004A1
(en)
*
|
2007-06-19 |
2008-12-25 |
Protia, Llc |
Deuterium-enriched clopidogrel
|
EP2170828B1
(en)
|
2007-06-20 |
2012-11-21 |
Auspex Pharmaceuticals, Inc. |
Substituted n-aryl pyridinones as fibrotic inhibitors
|
US20080318915A1
(en)
*
|
2007-06-20 |
2008-12-25 |
Protia, Llc |
Deuterium-enriched fluticasone propionate
|
US7915309B2
(en)
*
|
2007-06-20 |
2011-03-29 |
Protia, Llc |
Deuterium-enriched oseltamivir
|
WO2009009531A2
(en)
*
|
2007-07-09 |
2009-01-15 |
Concert Pharmaceuticals Inc. |
Pyrimidinecarboxamide derivatives for the treatment of hiv infections
|
EP2170825A2
(en)
*
|
2007-07-30 |
2010-04-07 |
Auspex Pharmaceuticals, Inc. |
Substituted indoles
|
ES2425183T3
(es)
*
|
2007-08-14 |
2013-10-11 |
Concert Pharmaceuticals Inc. |
Derivados de oxazolidinonas sustituidas
|
US20090062283A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched linezolid
|
US20090062305A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched cetirizine
|
US20090062385A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched fesoterodine
|
US20090062399A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched sertraline
|
US20090062561A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched latanoprost
|
US20090062393A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched pregabalin
|
US20090062299A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched doxazosin
|
US20090062316A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched pelitrexol
|
US20090062374A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched lasofoxifene
|
US20090069375A1
(en)
*
|
2007-09-09 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched miglustat
|
US20090069357A1
(en)
*
|
2007-09-09 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched iclaprim
|
US20090069413A1
(en)
*
|
2007-09-09 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched olopatadine
|
US20090069410A1
(en)
*
|
2007-09-09 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched paclitaxel
|
US20090069352A1
(en)
*
|
2007-09-09 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched clazosentan
|
US20090131485A1
(en)
*
|
2007-09-10 |
2009-05-21 |
Concert Pharmaceuticals, Inc. |
Deuterated pirfenidone
|
US20090069339A1
(en)
*
|
2007-09-11 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched ciprofloxacin
|
EP2197847B1
(en)
*
|
2007-09-12 |
2012-11-07 |
Concert Pharmaceuticals Inc. |
Deuterated 4 -oxoquinoline derivative for the treatment of hiv infection
|
US20090069431A1
(en)
*
|
2007-09-12 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched milnacipran
|
US8288414B2
(en)
*
|
2007-09-12 |
2012-10-16 |
Deuteria Pharmaceuticals, Inc. |
Deuterium-enriched lenalidomide
|
US20090076165A1
(en)
*
|
2007-09-12 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched memantine
|
CA2698808A1
(en)
|
2007-09-13 |
2009-03-19 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
|
US7919516B2
(en)
*
|
2007-09-13 |
2011-04-05 |
Protia, Llc |
Deuterium-enriched ondansetron
|
US20090076118A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched saxagliptin
|
US20090076116A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched carvediolo
|
US20090076010A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched lamotrigine
|
US20090076112A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched eltrombopag
|
US20090076161A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched bupropion
|
US20090075965A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched amoxicilin
|
US20090076038A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched entecavir
|
US20090075991A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched efavirenz
|
US20090075994A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched radafaxine
|
US20090076102A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched muraglitazar
|
US20090076025A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched dasatinib
|
US20090076148A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched pravastatin
|
US20090076039A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched valacyclovir
|
US20090076034A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched bms-690514
|
US20090076000A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched mycophenolate mofetil
|
US20090076018A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched ranolazine
|
US20090076017A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched trabectedin
|
US20090076157A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched senicapoc
|
US20090076164A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched tapentadol
|
US20090076163A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched dapoxetine
|
US20090076028A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched itraconazole
|
US20090076040A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched valganciclovir
|
US20090076138A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched darunavir
|
US20090075953A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched ed-71
|
US20090076264A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched rivaroxaban
|
US20090076128A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia Llc |
Deuterium-enriched topiramate
|
US20090075944A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched ibandronate
|
US20090076167A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched tramiprosate
|
US20090076117A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched laropiprant
|
US20090076126A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched enalapril
|
US20090118238A1
(en)
*
|
2007-09-17 |
2009-05-07 |
Protia, Llc |
Deuterium-enriched alendronate
|
US20090076027A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched lurasidone
|
US20090075947A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched fospropofol
|
US20090076134A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched simvastatin
|
US20090076144A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched bazedoxifene
|
US20090076058A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched finasteride
|
US20090076153A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched tigecycline
|
US20090076154A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched vorinostat
|
US20090075997A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched satavaptan
|
US20090076127A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched larotaxel
|
US20090076159A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched eplivanserin
|
US20090076011A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched tirapazamine
|
US20090082334A1
(en)
*
|
2007-09-25 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched quetiapine
|
US20090082323A1
(en)
*
|
2007-09-25 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched fulvestrant
|
US20090082382A1
(en)
*
|
2007-09-25 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched naltrexone
|
US20090082454A1
(en)
*
|
2007-09-25 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched disufenton
|
US20090082380A1
(en)
*
|
2007-09-25 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched rosuvastatin
|
US20090082312A1
(en)
*
|
2007-09-25 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched zoledronic acid
|
US20090082462A1
(en)
*
|
2007-09-25 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched armodafinil
|
US20090082376A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched alogliptin
|
US20090082436A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched rivastigmine
|
US20090082363A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched posaconazole
|
US20090082471A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched fingolimod
|
US20090082432A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched ramelteon
|
US8722710B2
(en)
|
2007-09-26 |
2014-05-13 |
Deuterx, Llc |
Deuterium-enriched pioglitazone
|
US20090082318A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched mometasone
|
US20090082442A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched lubiprostone
|
US20090082387A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched nvp-bez234
|
US20090082364A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched levocedtirizine
|
US20090082335A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched oxcarbazepine
|
US20090082452A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched lumiracoxib
|
US20090082459A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched guanfacine
|
WO2009051747A1
(en)
*
|
2007-10-15 |
2009-04-23 |
Concert Pharmaceuticals, Inc. |
Deuterated lorcaserin
|
EP2212298B1
(en)
*
|
2007-10-18 |
2013-03-27 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
WO2009054964A1
(en)
*
|
2007-10-22 |
2009-04-30 |
Concert Pharmaceuticals, Inc. |
Alpha-aminoamide derivatives
|
US20090131363A1
(en)
*
|
2007-10-26 |
2009-05-21 |
Harbeson Scott L |
Deuterated darunavir
|
US8592487B2
(en)
*
|
2007-10-26 |
2013-11-26 |
Concert Pharmaceuticals, Inc. |
Deuterated darunavir
|
US8093276B2
(en)
*
|
2007-10-31 |
2012-01-10 |
Bristol-Myers Squibb Company |
Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
|
WO2009061374A2
(en)
*
|
2007-11-02 |
2009-05-14 |
Concert Pharmaceuticals, Inc. |
Deuterated fingolimod
|
JP2011503231A
(ja)
*
|
2007-11-20 |
2011-01-27 |
コンサート ファーマシューティカルズ インコーポレイテッド |
Hcv感染処置のためのペプチド
|
ES2396366T3
(es)
*
|
2007-12-10 |
2013-02-21 |
Concert Pharmaceuticals Inc. |
Inhibidores heterocíclicos de quinasas
|
US8084464B2
(en)
*
|
2007-12-18 |
2011-12-27 |
Concert Pharmaceuticals, Inc. |
Tetrahydroisoquinoline derivatives
|
WO2009094210A1
(en)
*
|
2008-01-22 |
2009-07-30 |
Concert Pharmaceuticals Inc. |
Vandetanib derivatives
|
EP2242493B1
(en)
*
|
2008-01-22 |
2013-06-05 |
Concert Pharmaceuticals Inc. |
Derivatives of gefitinib
|
WO2009102707A2
(en)
*
|
2008-02-11 |
2009-08-20 |
Auspex Pharmaceuticals, Inc. |
Substituted oxazaphosphorines
|
US20090209550A1
(en)
*
|
2008-02-20 |
2009-08-20 |
Auspex Pharmaceuticals, Inc. |
Substituted triazolopyridines
|
EP2265334A2
(en)
|
2008-02-29 |
2010-12-29 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
WO2009114814A2
(en)
|
2008-03-14 |
2009-09-17 |
Retrotope, Inc. |
Therapeutic substances that modulate genome methylation
|
EP2268604B1
(en)
*
|
2008-03-14 |
2017-02-15 |
Retrotope, Inc. |
Therapies for cancer using isotopically substituted lysine
|
JP2011516426A
(ja)
*
|
2008-03-28 |
2011-05-26 |
コンサート ファーマシューティカルズ インコーポレイテッド |
キナゾリン誘導体および治療方法
|
JP2011518783A
(ja)
*
|
2008-04-09 |
2011-06-30 |
コンサート ファーマシューティカルズ インコーポレイテッド |
3−(2−ヒドロキシ−5−メチルフェニル)−n,n−ジイソプロピル−3−フェニルプロピルアミンの誘導体およびその使用方法
|
US8168814B2
(en)
*
|
2008-04-10 |
2012-05-01 |
New Mexico Highlands University |
Synthesis of phosphonic acid labeled compounds
|
US20100120786A1
(en)
*
|
2008-04-17 |
2010-05-13 |
Concert Pharmaceuticals, Inc. |
Piperazine Derivatives
|
US20110129549A1
(en)
*
|
2008-04-17 |
2011-06-02 |
Liu Julie F |
Tricyclic benzo[5,6]cyclohepta[1,2-b]pyridine derivatives and uses thereof
|
WO2009128947A1
(en)
*
|
2008-04-17 |
2009-10-22 |
Concert Pharmaceuticals, Inc. |
Piperazine derivatives
|
US20090285811A1
(en)
*
|
2008-05-13 |
2009-11-19 |
Auspex Pharmaceuticals, Inc. |
Anti-inflammatory and immunosuppressive glucocorticoid steroids
|
US20110160253A1
(en)
*
|
2008-05-28 |
2011-06-30 |
Harbeson Scott L |
Deuterated tizanidine
|
US8354557B2
(en)
*
|
2008-06-17 |
2013-01-15 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated morpholine derivatives
|
US20110294815A1
(en)
*
|
2008-06-27 |
2011-12-01 |
Harbeson Scott L |
Prostacyclin analogs
|
US20100016365A1
(en)
*
|
2008-07-17 |
2010-01-21 |
Auspex Pharmaceuticals, Inc. |
Substituted 4-amino-piperidines
|
WO2010011868A2
(en)
*
|
2008-07-23 |
2010-01-28 |
Auspex Pharmaceuticals |
Pyridine sulfonamide modulators of endothelin-a-receptor
|
WO2010019557A1
(en)
*
|
2008-08-12 |
2010-02-18 |
Concert Pharmaceuticals Inc. |
N-phenyl-2-pyrimidineamine derivatives
|
PL2328414T3
(pl)
|
2008-08-29 |
2014-05-30 |
Concert Pharmaceuticals Inc |
Podstawione pochodne triazolo-pirydazyny
|
US20100105755A1
(en)
*
|
2008-09-12 |
2010-04-29 |
Auspex Pharmaceuticals, Inc. |
Substituted benzamide modulators of dopamine receptor
|
US8704001B2
(en)
*
|
2008-09-16 |
2014-04-22 |
Concert Pharmaceuticals, Inc. |
Deuterated 2-amino-3-hydroxypropanoic acid derivatives
|
WO2010033270A1
(en)
*
|
2008-09-17 |
2010-03-25 |
Auspex Pharmaceuticals, Inc. |
Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
|
BRPI0913457B8
(pt)
*
|
2008-09-18 |
2021-08-31 |
Auspex Pharmaceutical Inc |
Composto e composição farmacêutica
|
BRPI0918760A2
(pt)
|
2008-09-19 |
2015-12-29 |
Concert Pharmaceuticals Inc |
compostos morfinanos
|
US20100087455A1
(en)
*
|
2008-10-06 |
2010-04-08 |
Auspex Pharmaceuticals, Inc. |
Substituted xanthine compounds
|
US20100099701A1
(en)
*
|
2008-10-20 |
2010-04-22 |
Auspex Pharmaceuticals, Inc. |
Isoquinolinone modulators of 5-ht3 receptors
|
US20100113431A1
(en)
*
|
2008-11-05 |
2010-05-06 |
Auspex Pharmaceuticals, Inc. |
N-methyl piperazine modulators of h1 receptor
|
US20100120733A1
(en)
*
|
2008-11-07 |
2010-05-13 |
Auspex Pharmaceuticals, Inc. |
Steroid modulators of glucocorticoid receptor
|
US8227451B2
(en)
*
|
2008-11-12 |
2012-07-24 |
Auspex Pharmaceuticals |
Phenylacetic acid inhibitors of cyclooxygenase
|
US9045453B2
(en)
|
2008-11-14 |
2015-06-02 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
US20100137215A1
(en)
*
|
2008-11-25 |
2010-06-03 |
Concert Pharmaceuticals Inc. |
Novel tetrahydro-1h-pyrido[4,3-b]indoles
|
WO2010065755A1
(en)
*
|
2008-12-04 |
2010-06-10 |
Concert Pharmaceuticals, Inc. |
Deuterated pyridinones
|
US20100143354A1
(en)
*
|
2008-12-04 |
2010-06-10 |
Auspex Pharmaceuticals, Inc. |
Triazine dna modifiers
|
US20100144657A1
(en)
*
|
2008-12-09 |
2010-06-10 |
Auspex Pharmaceuticals, Inc. |
PHENYLPIPERIDINE MODULATORS OF mu-OPIOID RECEPTORS
|
WO2010075086A2
(en)
*
|
2008-12-15 |
2010-07-01 |
Auspex Pharmaceuticals, Inc. |
Pyrrolidinone inhibitors of pde-4
|
AU2009330131B2
(en)
*
|
2008-12-23 |
2015-09-03 |
Aquilus Pharmaceuticals, Inc |
Compounds and methods for the treatment of pain and other diseases
|
US20120053159A1
(en)
*
|
2009-02-11 |
2012-03-01 |
Muller George W |
Isotopologues of lenalidomide
|
US8263601B2
(en)
*
|
2009-02-27 |
2012-09-11 |
Concert Pharmaceuticals, Inc. |
Deuterium substituted xanthine derivatives
|
US8952016B2
(en)
*
|
2009-02-27 |
2015-02-10 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
US8563554B2
(en)
|
2009-03-17 |
2013-10-22 |
Concert Pharmaceuticals, Inc. |
Deuterated pyrazinoisoquinoline compounds
|
US8044077B2
(en)
*
|
2009-03-19 |
2011-10-25 |
Bristol-Myers Squibb Company |
Alpha-(N-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production
|
US8778998B2
(en)
|
2009-04-10 |
2014-07-15 |
Auspex Pharmaceuticals, Inc. |
Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
|
CA2759026C
(en)
*
|
2009-04-20 |
2019-01-15 |
Auspex Pharmaceuticals, Inc. |
Piperidine inhibitors of janus kinase 3
|
US20100291151A1
(en)
*
|
2009-04-21 |
2010-11-18 |
Auspex Pharmaceuticals, Inc. |
1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor
|
US8461197B2
(en)
|
2009-04-23 |
2013-06-11 |
Concert Pharmaceuticals, Inc. |
4-hydroxybutyric acid analogs
|
US20100305173A1
(en)
*
|
2009-04-30 |
2010-12-02 |
Concert Pharmaceuticals, Inc. |
Hydroxyethylamino sulfonamide derivatives
|
US9468637B2
(en)
|
2009-05-13 |
2016-10-18 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
US8410082B2
(en)
|
2009-05-22 |
2013-04-02 |
Concert Pharmaceuticals, Inc. |
Fluorinated diaryl urea derivatives
|
US20110053968A1
(en)
*
|
2009-06-09 |
2011-03-03 |
Auspex Pharmaceuticals, Inc. |
Aminopyrimidine inhibitors of tyrosine kinase
|
US20120077851A1
(en)
*
|
2009-06-09 |
2012-03-29 |
Medolution Limited |
Urea Derivatives as Kinase Inhibitors
|
US8586760B2
(en)
*
|
2009-06-15 |
2013-11-19 |
Auspex Pharmaceuticals, Inc. |
Aminothiazole modulators of beta-3-adrenoreceptor
|
ME01883B
(me)
|
2009-06-18 |
2014-12-20 |
Concert Pharmaceuticals Inc |
Deuterijumski derivati izoindolin-1,3-diona kao inhibitori pde4 i tnf-alfa
|
US8501738B2
(en)
|
2009-06-23 |
2013-08-06 |
Concert Pharmaceuticals, Inc. |
Substituted triazolo-pyridazine derivatives
|
US20100325228A1
(en)
*
|
2009-06-23 |
2010-12-23 |
Alon Novy |
Systems and methods for distributed activity management system
|
WO2011009075A2
(en)
*
|
2009-07-17 |
2011-01-20 |
Rigel Pharmaceuticals, Inc. |
Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
|
EP2456311A4
(en)
*
|
2009-07-24 |
2013-01-23 |
Concert Pharmaceuticals Inc |
SUBSTITUTED IMIDASOTRIAZINES
|
US8802850B2
(en)
|
2009-07-27 |
2014-08-12 |
Auspex Pharmaceuticals, Inc. |
Cyclopropyl modulators of P2Y12 receptor
|
US8575348B2
(en)
*
|
2009-07-28 |
2013-11-05 |
Auspex Pharmaceuticals, Inc |
Quinolone inhibitors of lipoprotein-associated phospholipase A2
|
US9512104B2
(en)
|
2009-07-28 |
2016-12-06 |
Auspex Pharmaceuticals, Inc. |
Quinolone inhibitors of lipoprotein-associated phospholipase A2
|
US8637524B2
(en)
*
|
2009-07-28 |
2014-01-28 |
Auspex Pharmaceuticals, Inc |
Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2
|
US8618116B2
(en)
*
|
2009-08-03 |
2013-12-31 |
Daljit Singh Dhanoa |
Deuterium-enriched pyrimidine compounds and derivatives
|
EP2464355A4
(en)
*
|
2009-08-14 |
2013-01-02 |
Concert Pharmaceuticals Inc |
SUBSTITUTED TRIAZOLPHTHALAZINE DERIVATIVES
|
WO2011028820A1
(en)
|
2009-09-02 |
2011-03-10 |
Concert Pharmaceuticals, Inc. |
Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
|
US8278460B2
(en)
*
|
2009-10-15 |
2012-10-02 |
Concert Pharmaceuticals, Inc. |
Substituted benzimidazoles
|
US9260424B2
(en)
*
|
2009-10-26 |
2016-02-16 |
Auspex Pharmaceuticals, Inc. |
4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
|
KR20120092142A
(ko)
*
|
2009-10-28 |
2012-08-20 |
애나디스 파마슈티칼스, 인코포레이티드 |
중수소화 5,6-다이하이드로-1h-파이리딘-2-온 화합물
|
US20110117214A1
(en)
*
|
2009-11-16 |
2011-05-19 |
Auspex Pharmaceuticals, Inc. |
Cyclohexyl urea modulators of d2 receptors and/or d3 receptors
|
US8471034B2
(en)
*
|
2009-11-18 |
2013-06-25 |
Concert Pharmaceuticals, Inc. |
Niacin prodrugs and deuterated versions thereof
|
WO2011061243A1
(en)
*
|
2009-11-21 |
2011-05-26 |
F. Hoffmann-La Roche Ag |
Heterocyclic antiviral compounds
|
US20110152303A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Glaxosmithkline Llc |
Chemical Compounds
|
US20110178180A1
(en)
*
|
2010-01-18 |
2011-07-21 |
Kurt Nielsen |
Deuterium-enriched colchicine, thiocolchicine, and derivatives thereof; methods of preparation; and use thereof
|
US20110195066A1
(en)
*
|
2010-02-05 |
2011-08-11 |
Auspex Pharmaceuticals, Inc. |
Quinoline inhibitors of tyrosine kinase
|
BR112012020585A2
(pt)
*
|
2010-02-24 |
2018-04-17 |
Auspex Pharmaceuticals Inc |
composto, composição farmacêutica e método de tratamento de um distúrbio mediado por tirosina quinase
|
EP2542075A4
(en)
*
|
2010-03-01 |
2014-11-05 |
Concert Pharmaceuticals Inc |
Fluorouracil DERIVATIVES
|
WO2011109464A1
(en)
*
|
2010-03-02 |
2011-09-09 |
Concert Pharmaceuticals Inc. |
Deuterated tetrahydronaphthalene derivatives
|
US8575361B2
(en)
|
2010-03-02 |
2013-11-05 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
US8575221B2
(en)
|
2010-03-17 |
2013-11-05 |
Concert Pharmaceuticals, Inc. |
Derivatives of dimethylcurcumin
|
WO2012009446A1
(en)
|
2010-07-16 |
2012-01-19 |
Concert Pharmaceuticals Inc. |
Novel pyrimidinecarboxamide derivatives
|
WO2012031072A1
(en)
|
2010-09-01 |
2012-03-08 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
US9074233B2
(en)
|
2010-09-01 |
2015-07-07 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
CA2810092A1
(en)
*
|
2010-09-03 |
2012-03-08 |
IVAX International GmbH |
Deuterated analogs of pridopidine useful as dopaminergic stabilizers
|
IT1402047B1
(it)
*
|
2010-10-19 |
2013-08-28 |
Cross Pharma Sa |
Uso del mexiprostil nel trattamento delle malattie infiammatorie intestinali
|
CN102464652B
(zh)
*
|
2010-11-02 |
2013-08-28 |
北京欧博方医药科技有限公司 |
咪唑衍生物、制备方法及用途
|
CN103619334A
(zh)
*
|
2011-01-19 |
2014-03-05 |
朱红文 |
噻唑烷衍生物和其治疗用途
|
WO2012102387A1
(ja)
*
|
2011-01-27 |
2012-08-02 |
日産化学工業株式会社 |
ピラゾール誘導体及び有害生物防除剤
|
ES2804540T3
(es)
|
2011-02-14 |
2021-02-08 |
Concert Pharmaceuticals Inc |
Análogos deuterados de ácido 4hidroxibutírico
|
WO2012112558A1
(en)
|
2011-02-14 |
2012-08-23 |
The Regents Of The University Of Michigan |
Compositions and methods for the treatment of obesity and related disorders
|
US9145390B2
(en)
|
2011-03-03 |
2015-09-29 |
Concert Pharmaceuticals, Inc. |
Derivatives of pyrazole-substituted amino-heteroaryl compounds
|
US8889687B2
(en)
|
2011-03-04 |
2014-11-18 |
Concert Pharmaceuticals, Inc. |
Deuterated pyrazinoisoquinoline compounds
|
AU2012225611B2
(en)
|
2011-03-08 |
2016-09-15 |
Auspex Pharmaceuticals, Inc. |
Substituted N-Aryl pyridinones
|
WO2012135299A1
(en)
|
2011-03-28 |
2012-10-04 |
Deuteria Pharmaceuticals Inc |
2',6'-dioxo-3'-deutero-piperdin-3-yl-isoindoline compounds
|
US20140213553A1
(en)
*
|
2011-05-03 |
2014-07-31 |
Concert Pharmaceuticals Inc. |
Carbamoylpyridone derivatives
|
WO2012151343A1
(en)
*
|
2011-05-04 |
2012-11-08 |
Balance Therapeutics, Inc. |
Pentylenetetrazole derivatives
|
HUE047354T2
(hu)
|
2011-05-18 |
2020-04-28 |
Vertex Pharmaceuticals Europe Ltd |
Ivacaftor deuterizált származékai
|
EP2739617A4
(en)
*
|
2011-07-27 |
2015-01-28 |
Nanjing Allgen Pharma Co Ltd |
SPIROCYCLIC MOLECULES AS PROTEIN KINASE INHIBITORS
|
US8389723B1
(en)
*
|
2011-08-24 |
2013-03-05 |
Glaxosmithkline Llc |
Deuterated benzene sulfonamide thiazole compounds
|
IL298436B1
(en)
|
2012-01-23 |
2024-03-01 |
Sage Therapeutics Inc |
Pharmaceutical preparations that include allopregnanolone
|
BR112014019351A8
(pt)
*
|
2012-02-08 |
2017-07-11 |
Merck Patent Gmbh |
Análogos de tiazolidinona deuterados como agonistas para o receptor do hormônio folículo estimulante
|
IN2014DN08443A
(da)
*
|
2012-04-13 |
2015-05-08 |
Concert Pharmaceuticals Inc |
|
WO2013159026A1
(en)
|
2012-04-20 |
2013-10-24 |
Concert Pharmaceuticals, Inc. |
Deuterated rigosertib
|
WO2013168013A2
(en)
*
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of chronic diseases and inflammatory disorders
|
US20150197525A1
(en)
*
|
2012-06-15 |
2015-07-16 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of ruxolitinib
|
WO2014008417A1
(en)
|
2012-07-04 |
2014-01-09 |
Concert Pharmaceuticals, Inc. |
Deuterated vercirnon
|
EP2885267B1
(en)
|
2012-07-12 |
2018-09-05 |
Concert Pharmaceuticals, Inc. |
Deuterated idebenone
|
MX2015001246A
(es)
|
2012-07-30 |
2015-04-10 |
Concert Pharmaceuticals Inc |
Ibrutinib deuterado.
|
GB201214169D0
(en)
*
|
2012-08-08 |
2012-09-19 |
Biostatus Ltd |
New compounds and uses thereof
|
EA031716B1
(ru)
|
2012-08-17 |
2019-02-28 |
Консерт Фармасьютикалс, Инк. |
Дейтерированный барицитиниб
|
US20150210624A1
(en)
*
|
2012-08-22 |
2015-07-30 |
Concert Pharmaceuticals, Inc. |
Deuterated 4-hydroxybutyric acid analogs
|
AU2013312420A1
(en)
*
|
2012-09-07 |
2015-02-26 |
Axikin Pharmaceuticals, Inc. |
Isotopically enriched arylsulfonamide CCR3 antagonists
|
NZ705372A
(en)
|
2012-09-18 |
2018-07-27 |
Auspex Pharmaceuticals Inc |
Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
|
US9550780B2
(en)
|
2012-09-18 |
2017-01-24 |
Auspex Pharmaceuticals, Inc. |
Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
|
US9643950B2
(en)
|
2012-10-22 |
2017-05-09 |
Concert Pharmaceuticals, Inc. |
Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2-yl)(piperidine-3,4,4,5,5-d5)-2,6-dione}
|
AU2014205472B2
(en)
|
2013-01-09 |
2018-05-10 |
Concert Pharmaceuticals Inc. |
Deuterated momelotinib
|
CA2935495C
(en)
|
2013-01-14 |
2021-04-20 |
Deuterx, Llc |
3-(5-substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives
|
JP2016506957A
(ja)
*
|
2013-01-31 |
2016-03-07 |
オースペックス・ファーマシューティカルズ・インコーポレイテッドAuspex Pharmaceuticals, Inc. |
Vmat2のベンゾキノロン阻害剤
|
US20140221369A1
(en)
*
|
2013-02-01 |
2014-08-07 |
Deuterx, Llc |
5-deutero-2,4-thiazolidinedione and 5-deutero-2,4-oxazolidinedione derivatives and compositions comprising and methods of using the same
|
GB201302368D0
(en)
*
|
2013-02-11 |
2013-03-27 |
Univ Bath |
Compound
|
US9801882B2
(en)
|
2013-02-17 |
2017-10-31 |
Intra-Cellular Therapies, Inc. |
Phosphodiesterase-1 inhibitors and their use in treatment of cardiovascular diseases
|
WO2014152843A1
(en)
|
2013-03-14 |
2014-09-25 |
Deuterx, Llc |
Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
|
WO2014152833A1
(en)
|
2013-03-14 |
2014-09-25 |
Deuterx, Llc |
3-(substituted-4-oxo-quinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives
|
CA2906396A1
(en)
|
2013-03-15 |
2014-09-25 |
Concert Pharmaceuticals Inc. |
Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase
|
US9365581B2
(en)
*
|
2013-05-02 |
2016-06-14 |
The Regents Of The University Of Michigan |
Deuterated amlexanox
|
WO2015031741A1
(en)
|
2013-08-30 |
2015-03-05 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of a thienotriazolodiazapine bromodomain-containing protein inhibitor
|
AU2014332080B2
(en)
|
2013-10-08 |
2020-02-27 |
AI Therapeutics, Inc. |
Rapamycin for the treatment of lymphangioleiomyomatosis
|
EA201791466A1
(ru)
|
2013-12-03 |
2017-11-30 |
Оспекс Фармасьютикалз, Инк. |
Способы получения соединений бензохинолина
|
DK3077397T3
(da)
*
|
2013-12-06 |
2019-12-16 |
Vertex Pharma |
2-amino-6-fluor-n-[5-fluor-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamidforbindelse anvendelig som atr-kinase-inhibitor, dens fremstilling, forskellige faste former og radiomarkerede derivater deraf
|
US9732031B2
(en)
|
2013-12-20 |
2017-08-15 |
Deuterx, Llc |
Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion
|
WO2015109037A1
(en)
|
2014-01-15 |
2015-07-23 |
Deuterx, Llc |
Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
|
AU2015209330A1
(en)
*
|
2014-01-27 |
2016-07-28 |
Auspex Pharmaceuticals, Inc. |
Benzoquinoline inhibitors of vesicular monoamine transporter 2
|
CN104817559B
(zh)
*
|
2014-01-30 |
2021-05-25 |
苏州泽璟生物制药股份有限公司 |
氘代喹唑啉酮化合物以及包含该化合物的药物组合物
|
JP6526060B2
(ja)
|
2014-02-10 |
2019-06-05 |
コンサート ファーマシューティカルズ インコーポレイテッド |
置換トリアゾロベンゾジアゼピン
|
US10301268B2
(en)
|
2014-03-13 |
2019-05-28 |
The Salk Institute For Biological Studies |
Analogs of fexaramine and methods of making and using
|
EP3125893B1
(en)
*
|
2014-04-04 |
2023-09-20 |
Intra-Cellular Therapies, Inc. |
Deuterated heterocycle fused gamma-carbolines as antagonists of 5-ht2a receptors
|
JP6525285B2
(ja)
|
2014-04-04 |
2019-06-05 |
エイアイ・セラピューティクス・インコーポレーテッド |
加齢関連状態を処置するための吸入可能なラパマイシン配合物
|
CN104059030B
(zh)
*
|
2014-05-30 |
2016-05-04 |
镇江圣安医药有限公司 |
[(苯硫烷基)-苯基]哌嗪的衍生物及其药物组合物和用途
|
US9884872B2
(en)
*
|
2014-06-20 |
2018-02-06 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
DK3177627T3
(da)
|
2014-08-07 |
2019-10-21 |
Intra Cellular Therapies Inc |
Imidazo[1,2-a]-pyrazolo[4,3-e]-pyrimidin-4-on-derivater med pde1-hæmmende aktivitet
|
KR20170095807A
(ko)
*
|
2014-10-07 |
2017-08-23 |
램 테라퓨틱스, 인코포레이티드 |
폐 고혈압의 치료를 위한 흡입가능 라파마이신 제제
|
US10160778B2
(en)
|
2014-10-27 |
2018-12-25 |
Concert Pharmaceuticals, Inc. |
Pyrimidine phosphonic acid esters
|
US11578097B2
(en)
|
2014-11-26 |
2023-02-14 |
Enanta Pharmaceuticals, Inc. |
Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof
|
CA2966452A1
(en)
*
|
2014-12-17 |
2016-06-23 |
Samuel David Brown |
Substituted bicyclic compounds as bromodomain inhibitors
|
US20180022710A1
(en)
|
2015-01-29 |
2018-01-25 |
Signal Pharmaceuticals, Llc |
Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
|
CN105985396A
(zh)
*
|
2015-02-16 |
2016-10-05 |
苏州泽璟生物制药有限公司 |
氘代鹅去氧胆酸衍生物以及包含该化合物的药物组合物
|
EA201791977A1
(ru)
|
2015-03-06 |
2018-01-31 |
Оспекс Фармасьютикалз, Инк. |
Способы лечения патологических непроизвольных движений
|
WO2016160945A1
(en)
|
2015-03-31 |
2016-10-06 |
Concert Pharmaceuticals, Inc. |
Deuterated vx-661
|
EP3280420B1
(en)
*
|
2015-04-10 |
2024-03-27 |
Sage Therapeutics, Inc. |
Compositions and methods for treating cns disorders
|
US10683305B2
(en)
*
|
2015-04-27 |
2020-06-16 |
Concert Pharmaceuticals, Inc. |
Deuterated OTX-015
|
CN107698620A
(zh)
*
|
2015-06-23 |
2018-02-16 |
江苏天士力帝益药业有限公司 |
一种氘代噻吩并哌啶衍生物、制备方法及其应用
|
JP6595011B2
(ja)
*
|
2015-06-26 |
2019-10-23 |
重▲慶▼迪康▲爾▼▲楽▼制▲薬▼有限公司 |
新規ホスホジエステラーゼ5阻害剤とその使用
|
US9809603B1
(en)
|
2015-08-18 |
2017-11-07 |
Deuterx, Llc |
Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same
|
MA42954A
(fr)
|
2015-09-25 |
2018-08-01 |
Vertex Pharmaceuticals Europe Ltd |
Potentialisateurs cftr deutérés
|
EP3365336B1
(en)
*
|
2015-10-21 |
2023-07-26 |
Neuform Pharmaceuticals, Inc. |
Deuterated compounds for treating hematologic malignancies, and compositions and methods thereof
|
WO2017087795A1
(en)
|
2015-11-19 |
2017-05-26 |
Concert Pharmaceuticals, Inc. |
Deuterated epi-743
|
EP3407888B1
(en)
|
2016-01-26 |
2020-12-30 |
Intra-Cellular Therapies, Inc. |
Pyridopyrroloquinoxaline compounds, their compositions and uses
|
EP3407974A4
(en)
|
2016-01-29 |
2019-08-28 |
The Regents Of The University Of Michigan |
ANALOGUES OF AMLEXANOX
|
WO2017133360A1
(zh)
*
|
2016-02-02 |
2017-08-10 |
深圳市塔吉瑞生物医药有限公司 |
一种甾体类化合物及包含该化合物的组合物及其用途
|
EP3416629A4
(en)
|
2016-02-16 |
2019-08-07 |
CoNCERT Pharmaceuticals, Inc. |
DEUTERATED GFT-505
|
US10364267B2
(en)
*
|
2016-02-23 |
2019-07-30 |
Enanta Pharmaceuticals, Inc. |
Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
|
MA43815A
(fr)
|
2016-03-08 |
2021-04-07 |
Sage Therapeutics Inc |
Stéroïdes neuroactifs, compositions, et leurs utilisations
|
EP3888656A1
(en)
|
2016-03-25 |
2021-10-06 |
Intra-Cellular Therapies, Inc. |
Deuterated heterocyclic gamma-carboline compounds and their use in the treatment or prophylaxis of a central nervous system disorder
|
JP2019510039A
(ja)
|
2016-03-28 |
2019-04-11 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
新規組成物および方法
|
WO2018002673A1
(en)
|
2016-07-01 |
2018-01-04 |
N4 Pharma Uk Limited |
Novel formulations of angiotensin ii receptor antagonists
|
WO2018126143A1
(en)
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
WO2018126140A1
(en)
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
CN114805211A
(zh)
|
2017-03-21 |
2022-07-29 |
润佳(苏州)医药科技有限公司 |
同位素富集3-氨基-1-丙磺酸衍生物、药物组合物及其用途
|
MX2021013640A
(es)
|
2017-03-24 |
2022-08-31 |
Intra Cellular Therapies Inc |
Composiciones novedosas y metodos.
|
WO2018187804A1
(en)
|
2017-04-07 |
2018-10-11 |
Enanta Pharmaceuticals, Inc. |
Process for preparation of sulfonyl carbamate bile acid derivatives
|
CA3063901A1
(en)
*
|
2017-05-16 |
2018-11-22 |
Vertex Pharmaceuticals Incorporated |
Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
|
WO2019104179A1
(en)
|
2017-11-22 |
2019-05-31 |
Concert Pharmaceuticals, Inc. |
Deuterated analogs of d-serine and uses thereof
|
SG11202004264VA
(en)
|
2017-12-01 |
2020-06-29 |
Vertex Pharma |
Processes for making modulators of cystic fibrosis transmembrane conductance regulator
|
JP7150356B2
(ja)
*
|
2017-12-22 |
2022-10-11 |
深▲チェン▼市塔吉瑞生物医薬有限公司 |
置換ピラゾロ[1,5-a]ピリミジン化合物並びにその医薬組成物および使用
|
WO2019144885A1
(zh)
|
2018-01-23 |
2019-08-01 |
深圳市塔吉瑞生物医药有限公司 |
取代的吡唑并[1,5-a]嘧啶类的大环化合物
|
WO2019152697A1
(en)
|
2018-01-31 |
2019-08-08 |
Intra-Cellular Therapies, Inc. |
Novel uses
|
CN109970745B
(zh)
*
|
2018-04-16 |
2020-12-08 |
深圳市塔吉瑞生物医药有限公司 |
取代的吡咯并三嗪类化合物及其药物组合物及其用途
|
EP3810134A4
(en)
*
|
2018-06-19 |
2022-03-30 |
Celecor Therapeutics, Inc. |
DEUTERED RUC-4
|
US20210283132A1
(en)
*
|
2018-07-12 |
2021-09-16 |
Shenzhen Targetrx, Inc. |
Diarylpyrazole compound, composition comprising same, and use thereof
|
BR112021003655A2
(pt)
|
2018-08-31 |
2021-05-18 |
Intra-Cellular Therapies, Inc. |
métodos novos
|
CA3108558A1
(en)
|
2018-08-31 |
2020-03-05 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
CN111116492B
(zh)
*
|
2019-01-25 |
2021-07-09 |
青岛吉澳医药科技有限公司 |
氘代苯甲氨嘧啶二酮衍生物及其用途
|
US11116737B1
(en)
|
2020-04-10 |
2021-09-14 |
University Of Georgia Research Foundation, Inc. |
Methods of using probenecid for treatment of coronavirus infections
|
US11319313B2
(en)
|
2020-06-30 |
2022-05-03 |
Poxel Sa |
Crystalline forms of deuterium-enriched pioglitazone
|
US11767317B1
(en)
|
2020-06-30 |
2023-09-26 |
Poxel Sa |
Methods of synthesizing enantiopure deuterium-enriched pioglitazone
|
US20230150965A1
(en)
*
|
2021-11-05 |
2023-05-18 |
Terran Biosciences, Inc. |
Isotopically enriched n-methyl-1,3-benzodioxolylbutanamine (mbdb) and stereoisomers thereof
|
US20230202998A1
(en)
|
2021-11-17 |
2023-06-29 |
Terran Biosciences, Inc. |
Phenethylamine compounds salts, polymorphic forms and methods of use thereof
|